168 related articles for article (PubMed ID: 22445792)
1. HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?
Campoli M; Fitzpatrick JE; High W; Ferrone S
J Am Acad Dermatol; 2012 Jun; 66(6):911-6, 916.e1-8. PubMed ID: 22445792
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
Ruiter DJ; Bergman W; Welvaart K; Scheffer E; van Vloten WA; Russo C; Ferrone S
Cancer Res; 1984 Sep; 44(9):3930-5. PubMed ID: 6204749
[TBL] [Abstract][Full Text] [Related]
3. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
[TBL] [Abstract][Full Text] [Related]
4. Beta 2 microglobulin expression in normal melanocytes, nevocellular nevi, and malignant melanomas.
Takata M; Hirone T; Matsumura H
J Invest Dermatol; 1989 May; 92(5 Suppl):243S-247S. PubMed ID: 2654298
[TBL] [Abstract][Full Text] [Related]
5. Architectural features in melanocytic lesions with cellular atypia.
Balkau D; Gartmann H; Wischer W; Grootens A; Hagemeier HH; Hundeiker M; Suter L
Dermatologica; 1988; 177(3):129-37. PubMed ID: 3169338
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
[TBL] [Abstract][Full Text] [Related]
7. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
Hastrup N; Hou-Jensen K
APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
[TBL] [Abstract][Full Text] [Related]
8. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.
Bergman W; Ruiter DJ; Scheffer E; van Vloten WA
Cancer; 1988 Apr; 61(8):1660-6. PubMed ID: 3349425
[TBL] [Abstract][Full Text] [Related]
9. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
[TBL] [Abstract][Full Text] [Related]
10. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi.
Shea CR; Vollmer RT; Prieto VG
Hum Pathol; 1999 May; 30(5):500-5. PubMed ID: 10333217
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
12. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
13. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
14. The significance of Melan-A-positive pagetoid melanocytosis in dysplastic nevi.
Huwait H; Hijazi N; Martinka M; Crawford RI
Am J Dermatopathol; 2014 Apr; 36(4):340-3. PubMed ID: 24736669
[TBL] [Abstract][Full Text] [Related]
15. Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers.
Le YS; Kim TE; Kim BK; Park YG; Kim GM; Jee SB; Ryu KS; Kim IK; Kim JW
Exp Mol Med; 2002 Mar; 34(1):18-26. PubMed ID: 11989974
[TBL] [Abstract][Full Text] [Related]
16. Atypical melanocytic lesions of the thigh with spitzoid and dysplastic features: a clinicopathologic study of 29 cases.
Buonaccorsi JN; Lynott J; Plaza JA
Ann Diagn Pathol; 2013 Jun; 17(3):265-9. PubMed ID: 23312707
[TBL] [Abstract][Full Text] [Related]
17. The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
Fraga-Braghiroli N; Grant-Kels JM; Oliviero M; Rabinovitz H; Ferenczi K; Scope A
J Am Acad Dermatol; 2020 Oct; 83(4):1035-1043. PubMed ID: 32442695
[TBL] [Abstract][Full Text] [Related]
18. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
19. Expression and distribution of transforming growth factor-alpha within melanocytic lesions.
Nanney LB; Coffey RJ; Ellis DL
J Invest Dermatol; 1994 Nov; 103(5):707-14. PubMed ID: 7963661
[TBL] [Abstract][Full Text] [Related]
20. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
Smoller BR; McNutt NS; Hsu A
Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]